Last reviewed · How we verify
Radiotherapy Combined With Realgar-Indigo Naturalis Formula (RIF) in the Treatment of Rhabdomyosarcoma(RMS) in Children
The goal of this clinical trial\]is to evaluate the efficacy, safety and feasibility of radiotherapy combined with Realgar-Indigo naturalis formula（An oral arsenic agent）in the treatment of rhabdomyosarcoma in children. Including the occurrence of adverse events and the improvement of quality of life.
Details
| Lead sponsor | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine |
|---|---|
| Phase | PHASE2 |
| Status | UNKNOWN |
| Enrolment | 53 |
| Start date | Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Dec 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Rhabdomyosarcoma, Child
Interventions
- Realgar-Indigo Naturalis Formulation
- Radiotherapy